Actively Recruiting
Digital Intelligence Early Warning System for Acute Lung Injury During Major Liver Surgery Based on Cardiopulmonary Interaction
Led by Beijing Tsinghua Chang Gung Hospital · Updated on 2025-07-17
4000
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are developing a machine learning model to predict acute lung injury (ALI) early in patients undergoing major liver surgery. This study focuses on using cardiopulmonary interaction data collected before, during, and after surgery to create a digital early-warning system. The goal is to support clinical decisions, reduce ALI cases, and lower death rates related to this complication. The study involves gathering data from adult patients who have major liver surgeries such as two-segment or larger hepatectomy or liver transplantation. It includes both retrospective and prospective groups, with no new treatments or medications given as part of the study. Instead, clinical care follows usual protocols, and the machine learning model is developed using methods like logistic regression, random forest, support vector machines, and neural networks. The model's accuracy and other performance metrics will be tested to ensure reliability. Participants will have their routine medical data collected throughout the surgical process, from one day before surgery to seven days after, to monitor for ALI occurrence. Researchers will evaluate the model's ability to predict ALI during this perioperative period. There are no study interventions, and patient care remains standard. The study aims to improve early detection tools to aid doctors in managing and treating ALI in liver surgery patients.
CONDITIONS
Brief Title
Digital Early Warning System for Acute Lung Injury in Liver Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Undergoing major liver surgery, including two-segment or more hepatectomy or liver transplantation
- Voluntary participation with signed informed consent
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 1 day before surgery
Data are collected from preoperative assessments before major liver surgery.
1 visit (in-person)
Duration - From surgery day to 7 days after surgery
Participants undergoing major liver surgery are observed during the intraoperative and postoperative periods with data collected from routine clinical care to predict acute lung injury.
Data collection during hospital stay, including intraoperative and postoperative monitoring visits
Trial Site Locations
Total: 1 location
1
Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine,Tsinghua University
Beijing, Beijing Municipality, China, 102218
Actively Recruiting
Research Team
G
Gao Zhifeng, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here